Showing results (101-110 of 150) with videos related to

Sort By:
Pageof 15
Rheumatology (Oxford, England)|December 17, 2020
The management of Sjögren's syndrome: British Society for Rheumatology guideline scopeElizabeth Price, Alexander Allen, Saaeha Rauz, et al.
Pathogens & Immunity|June 14, 2016
Hepatitis Delta Virus Detected in Salivary Glands of Sjögren's Syndrome Patients and Recapitulates a Sjögren's Syndrome-Like Phenotype in VivoMelodie L Weller, Matthew R Gardener, Zoe C Bogus, et al.
Arthritis Research & Therapy|May 4, 2018
Integrative analysis reveals CD38 as a therapeutic target for plasma cell-rich pre-disease and established rheumatoid arthritis and systemic lupus erythematosusSuzanne Cole, Alice Walsh, Xuefeng Yin, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 20, 2015
IL-22 regulates lymphoid chemokine production and assembly of tertiary lymphoid organsFrancesca Barone, Saba Nayar, Joana Campos, et al.
Nature Communications|March 17, 2024
Axl and MerTK regulate synovial inflammation and are modulated by IL-6 inhibition in rheumatoid arthritisAlessandra Nerviani, Marie-Astrid Boutet, Giulia Maria Ghirardi, et al.
Plos One|March 1, 2018
Immune checkpoint inhibitor PD-1 pathway is down-regulated in synovium at various stages of rheumatoid arthritis disease progressionYanxia Guo, Alice M Walsh, Mary Canavan, et al.
Annals of the Rheumatic Diseases|December 15, 2016
Standardisation of labial salivary gland histopathology in clinical trials in primary Sjögren's syndromeBenjamin A Fisher, Roland Jonsson, Troy Daniels, et al.
Rheumatology (Oxford, England)|November 22, 2020
Advanced imaging for quantification of abnormalities in the salivary glands of patients with primary Sjögren's syndromePilar Jimenez-Royo, Michele Bombardieri, Coziana Ciurtin, et al.
BMJ Open|March 3, 2026
Pragmatic, open-label, multicentre, randomised controlled trial to guide initial therapy for immune checkpoint inhibitor-induced inflammatory arthritis comparing standard of care (prednisolone) to adalimumab without glucocorticoids: REACT trial protocolBenjamin A Fisher, Anna Rowe, Chris Hodson, et al.
Rheumatology (Oxford, England)|April 15, 2024
British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren diseaseElizabeth J Price, Stuart Benjamin, Michele Bombardieri, et al.
Pageof 15